Who Owns the Finding? Physician Oversight and Accountability in Pre-Bill Revenue Integrity
A technology-assisted pre-bill review identifies a potential diagnosis-related group (DRG), coding, or documentation opportunity. The recommendation is accepted, the claim is submitted, and the financial impact appears measurable. Months later, a payer challenges the decision.
At that point, the most important question is no longer whether the technology detected an opportunity. It is who validated the clinical support, what evidence was retained, and who will stand behind the decision through the denial process.
That is the accountability gap health-system executives should examine when evaluating physician oversight within their revenue integrity programs. Automation can accelerate detection, but an accountable operating model must carry each supported finding from identification through validation, action and—when necessary—defense.
This is not an argument against automation. It is a framework for determining whether a pre-bill review program produces recommendations the organization can act on with confidence.
The strongest operating models do not rely on technology, coding expertise, or physician judgment in isolation. They combine complete-record analysis by experienced, clinically trained coding specialists with physician validation of every developed finding. This dual-expertise model creates the accountability required to turn a technology-generated signal into a recommendation the health system can use—and defend—with confidence.
The Financial Risk Begins Before the Denial
A denial may arrive after the original reviewers have moved on, the underlying technology has changed, or the rationale for the recommendation has been reduced to an alert or report. Reconstructing the decision later creates avoidable cost: staff time, delayed cash, appeal preparation, physician rework, and the possibility that a clinically appropriate claim cannot be defended as clearly as it should be.
The solution is to establish an ownership chain before billing. Every material recommendation should have a clear answer to four questions: Why was the chart surfaced? Who reviewed the complete record? Which physician validated the finding? What support remains available if the payer challenges it?
Four Questions Define Accountability
| Decision Point | Executive Question | What Good Looks Like |
| 1. Detect | Why was the chart surfaced? | The triggering data, logic, documentation, or coding relationship is visible. |
| 2. Validate | Does the complete record support the finding? | Experienced, clinically trained coding analysts evaluate the complete record and apply current coding rules and guidelines. Physician advisors with coding expertise then validate the developed finding for clinical support, appropriateness, and defensibility. |
| 3. Act | Should the organization query, change, or retain the claim? | The recommendation is supported, documented, and routed through the health system’s established process. |
| 4. Defend | What happens if the payer disagrees? | The original reasoning and evidence remain available, with clinical escalation or appeal support when needed. |
AHIMA and ACDIS guidance makes the accountability standard clear: technology-generated queries are subject to the same compliance requirements as manually generated queries. Query professionals remain responsible for distinguishing legitimate opportunities from inappropriate triggers, and the supporting clinical indicators must be specific to the patient and episode of care.[1]
For a CFO, that means an alert is not yet an asset. It becomes financially meaningful only when it is converted into a supported decision with an accountable owner.
The Quality Advantage: Clinical Coding Analysis + Physician Validation
Physician oversight is most valuable when it is integrated with—not substituted for—specialized clinical coding analysis. Enjoin’s delivery model combines technology-enabled prioritization with two complementary layers of expert review: comprehensive clinical coding analysis and physician validation.
EnFORM+ analyzes the eligible inpatient population and prioritizes records that warrant deeper review. Experienced, clinically trained clinical coding analysts (CCAs) then perform complete-record reviews on prioritized cases. They evaluate the patient’s full clinical story, identify relevant coding and documentation relationships, and apply the interpretive nuance required by evolving coding rules and guidelines. This work converts a technology-generated signal into a thoroughly investigated, evidence-based finding.
Physician advisors with coding expertise then collaborate with the CCAs to review and approve 100% of the findings developed through that process before supported recommendations are returned to the health system.[2, 5] Physicians focus on closing the gap between clinical practice and coding requirements—particularly in clinically complex cases—so each recommendation reflects both evidence-based medicine and defensible coding logic.
A scalable model assigns each stage to the expertise best suited to it:
- Technology analyzes and prioritizes. EnFORM+ evaluates the eligible population and identifies records that warrant comprehensive review.
- Clinical coding analysts investigate and develop. CCAs evaluate the complete patient record, connect the clinical evidence to the documentation and relevant coding relationships, and develop well-supported findings.
- Physician advisors validate and approve. Physicians collaborate with CCAs to review every developed finding for clinical support, coding appropriateness, and defensibility.
- The health system makes the final decision. The client retains authority over all coding, query, and billing actions.
This integrated model delivers more than physician screening or coding review alone. It combines comprehensive coding analysis with physician clinical judgment to produce a higher-quality, more actionable recommendation. Physician oversight therefore functions as a finding-level accountability layer within a broader expert review process—not as a physician manually screening every eligible chart or reviewing every raw technology signal.
Why Physician Review of Every Finding Matters
Physicians review every developed Enjoin finding. Their clinical judgment becomes especially consequential when a finding involves:
- Competing principal diagnoses where the condition chiefly responsible for the admission is not immediately clear
- High-impact secondary diagnoses that could change severity or reimbursement but require stronger clinical support
- Conflicting, incomplete, or ambiguous documentation that may warrant clarification
- A technically possible query that may not be clinically appropriate
- DRGs or diagnoses receiving heightened payer scrutiny
- A denial or appeal that requires case-specific clinical reasoning
How Enjoin Assigns Ownership From Detection Through Defense
Each stage of the process is assigned to the expertise best suited to it, creating a defined ownership chain from population-level analysis through final client action and, when needed, denial defense.
| Stage | What Happens | Primary Role |
| Analyze and Prioritize | Analyze eligible inpatient discharges and prioritize records that warrant deeper review | EnFORM+ |
| Investigate and Develop | Evaluate the complete record and develop evidence-based findings using clinical and coding expertise | Clinical coding analysts |
| Validate and Approve | Review 100% of developed findings for clinical support, coding appropriateness, and defensibility | Physician advisors in collaboration with CCAs |
| Evaluate and Act | Assess the supported recommendation and authorize the final query, coding, DRG, or billing action | Health-system team |
| Defend | Apply retained evidence and case-specific clinical reasoning when a reviewed claim is challenged | Denial specialists and physician advisors, as appropriate |
This model is deliberate: technology provides population-level scale, CCAs provide comprehensive clinical coding analysis, and physician advisors provide clinical validation and accountability. The health system retains authority over the final action.
Seven Questions to Ask Before Selecting or Renewing a Pre-Bill Review Partner
1. Can we see—and reproduce—the evidence and logic behind each recommendation?
A useful recommendation should show why the chart was surfaced, identify the supporting documentation and clinical indicators, and explain the logic connecting that evidence to the proposed action. A qualified reviewer should be able to follow that logic beyond statistical associations and independently determine whether the recommendation is clinically supported and appropriate for further review.
2. Who investigates the complete record and develops the finding?
Ask whether experienced reviewers evaluate the patient’s complete clinical story and apply current coding rules and guidelines—or whether the internal team is expected to investigate an isolated technology alert. Reviewer credentials should reflect both coding proficiency and the clinical knowledge required to interpret complex documentation.
3. How is physician expertise integrated?
Determine whether physician involvement complements comprehensive clinical coding analysis or serves only as an occasional escalation. The partner should explain whether physicians collaborate with coding specialists, whether they review every developed finding, and how their clinical and coding expertise changes the final recommendation. “Physician-led” should describe a defined accountability process, not merely a branding claim.
4. Who authorizes the final action?
Clarify what the partner recommends, what the internal CDI or coding team reviews, and who retains authority for the final query, code, DRG, and claim.
5. How much work is transferred to our team?
Alert volume can increase internal labor. Measure the investigation, documentation, reconciliation, and physician follow-up required before a recommendation can be used.
6. What record of the decision is retained?
The organization should be able to reconstruct why a finding moved forward, who reviewed it, and what clinical and coding support was available at the time.
7. What happens if the claim is denied?
Ask whether the partner provides denial analysis, clinical review, or appeal support; whether that support is included in the engagement; and how denial outcomes improve future pre-bill decisions.
What Enjoin’s Review Model Produced Beyond AI-Only Review
An Enjoin case study examines an academic health system that made Enjoin’s technology-enabled, physician-led review its primary method after initially using an AI-driven prioritization platform. AI alerts remained in the workflow as a secondary, complementary layer.[3]
Across a review of 51 encounters, the case study reported $553,000 in financial opportunity attributed to Enjoin’s precision, technology-enabled physician reviews, compared with $78,000 originally attributed to AI-generated opportunities. It also reported that more than 50% of the AI alerts fell within the same DRG family that Enjoin physicians had already identified. The case study separately reported a 671% return on investment for EnFORM+ and Enjoin’s physician-directed review model.[3]
For CFOs, the point is not that AI lacks value. It is that alert volume and gross opportunity are weaker measures than validated, defensible yield. The comparison covers 51 encounters, comes from an Enjoin case study, and should not be treated as an independent evaluation or a guaranteed result.
It does, however, illustrate the operating model this article advocates: technology prioritizes potential opportunities, clinically trained coding analysts determine whether the complete record and coding logic support a finding, and physician advisors validate whether that finding is clinically appropriate and defensible.
Measure Ownership, Not Just Output
A revenue integrity program should not be judged solely by charts screened, alerts generated, or gross opportunity identified. Health-system executives should also examine accepted financial impact, internal labor required per recommendation, turnaround time, denial performance on reviewed cases, and whether the rationale for each material decision can be reconstructed.
The executive question is not whether a platform uses automation or whether a physician appears somewhere in the workflow. It is whether every material recommendation remains owned—from the moment it is detected to the moment it is accepted, rejected, or defended.
Frequently Asked Questions
Does physician oversight mean a physician reviews every chart?
No. EnFORM+ analyzes the eligible chart population, and clinical coding analysts perform complete-record review on prioritized cases. Enjoin physicians review 100% of the findings produced through that process before supported recommendations are returned to the health system.[2, 5]
How does Enjoin apply physician oversight to the review process?
Enjoin combines two distinct forms of expertise. EnFORM+ analyzes the eligible chart population, and experienced, clinically trained clinical coding analysts (CCAs) perform complete-record reviews on prioritized cases. CCAs are trained to identify coding opportunities within the context of the patient’s full clinical story while applying current coding rules and guidelines.
Physician advisors with coding expertise then collaborate with the CCAs to review and approve 100% of the findings developed through that process before supported recommendations are returned to the health system.[2, 5] Their role is to close the gap between clinical practice and coding requirements—particularly in complex cases—so each recommendation reflects both evidence-based medicine and defensible coding logic.
This integrated CCA-and-physician model delivers more than physician screening alone: it combines comprehensive coding analysis with clinical validation to produce a higher-quality, more actionable finding.
How does CDI physician oversight support an in-house CDI team?
CDI physician oversight should add specialized clinical escalation, complex-case review, denial insight, and peer-to-peer support. It should complement the internal team’s expertise and decision rights, not characterize the team as incapable or replace its established processes.
What is the difference between an audit trail and clinical defensibility?
An audit trail shows what happened and who took action. Clinical defensibility explains why the decision was appropriate for the specific patient record. A strong program needs both.
See how Enjoin combines technology-assisted detection, comprehensive CCA review, physician validation of every developed finding, and denial support to create recommendations health systems can act on with confidence.
Last updated: August 24, 2026
Sources
[1] American Health Information Management Association and Association of Clinical Documentation Integrity Specialists. Guidelines for Achieving a Compliant Query Practice (2022 Update). https://ahima.org/media/51ufzhgl/20221212_acdis_practice-brief.pdf
[2] Enjoin. How EnFORM+ Works: A Guide to Implementation, Scalability, and Defensible Revenue Impact. https://www.enjoincdi.com/blog/how-enform-works/
[3] Enjoin. How LCMC Health Recovered $13 Million in Uncaptured Revenue with Physician-Led Pre-Bill Reviews. https://www.enjoincdi.com/blog/how-lcmc-health-recovered-13-million-in-uncaptured-revenue-with-physician-led-pre-bill-reviews/
[4] Enjoin. Pre-Bill Chart Review. https://www.enjoincdi.com/solutions/pre-bill-chart-review/
[5] Enjoin internal operating model documentation. Physician review of 100% of findings, confirmed August 2026.